Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Craniopharyngioma × tovorafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Thyroid Cancer, Papillary 1 Pancreatic Neoplasms 1 Melanoma 1 Low-grade Glioma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Craniopharyngioma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Mental Status and Dementia Tests 2 trametinib 1 tozuleristide 1 tovorafenib 1 tocilizumab 1 dabrafenib 1 cobimetinib 1 binimetinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vemurafenib 1 Transurethral Resection of Bladder 1 Surgical Procedures, Operative 1 Radiotherapy 1 Qsymia 1 Proton Therapy 1 Phentermine 1 Oxytocin 1 Methionine 1 Memantine 1 Medication Errors 1 Ginkgo biloba extract 1 Exenatide 1 Donepezil 1 CKD732 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05465174 2026-03-09

PNOC029

University of California, San Francisco

Phase 2 Recruiting

Craniopharyngioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡